Poland· PL-100421626

Sorafenib Sandoz

A gefitinib product containing sorafenibum, registered in Poland by Sandoz GmbH. The same ATC class is registered in 13 of our 19 countries.

ATC L01EB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSorafenib SandozATCL01EB01REGISTER NO.PL-100421626PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Gefitinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L01EB01 (gefitinib), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Gefitinib · ATC L01EB01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of gefitinib costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Gefitinib · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$95.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Sorafenibum
Manufacturer
Sandoz GmbH
Country
Poland (PL)
ATC code
L01EB01
ATC class
Gefitinib
Defined daily dose
0.25 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    07613421047009

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

414 interactions on record for gefitinib.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gefitinib · interactions on record

414 records

  • 11 severe
  • 193 moderate
  • 5 minor
  • 205 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • Aminolevulinic acidL01XD04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gefitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gefitinib products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Sorafenib, Sorafenib Bluefish
  • Belgium · Sorafenib Eg, Sorafénib Eg
  • Bulgaria · Сорафениб Зентива, Сорафениб Тева
  • Cyprus · Rexanib
  • Czechia · Sorafenib Pharmagen, Sorafenib Sandoz
  • Germany · Sorafeb, Sorafenib Abz
  • Denmark · Sorafenib "sandoz", Sorafenib Stada
  • Estonia · Sorafenib Sandoz, Sorafenib Teva
  • Spain · Sorafenib Dr. Reddys, Sorafenib Eugia
  • Finland · Sorafenib Sandoz, Sorafenib Stada
  • France · Sorafenib Arrow, Sorafenib Biogaran
  • United Kingdom (Northern Ireland) · Sorafenib Sandoz, Sorafenib Teva
  • Greece · Revamox, Sorafenib Bioars
  • Croatia · Slam 200 Mg Tablete, Sorafenib Alpha-Medical
  • Hungary · Fenesa, Renixola
  • Iceland · Nexavar, Sorafenib
  • Italy · Sorafenib Eg, Sorafenib Medac
  • Liechtenstein · Nexavar, Sorafenib Accord
  • Lithuania · Sorafenib Sandoz, Sorafenib Teva
  • Luxembourg · Sorafenib Eg, Sorafenib Eurogenerics
  • Latvia · Sorafenib Lv System, Sorafenib Sandoz
  • Malta · Revamox, Sorafenib Pharos
  • Netherlands · Fenesa, Sorafeb
  • Norway · Nexavar, Sorafenib Accord
  • Portugal · Sorafenib, Sorafenib Eugia
  • Romania · Sorafenib Dr. Reddy's, Sorafenib Sandoz
  • Sweden · Sorafenib Bluefish, Sorafenib Sandoz
  • Slovenia · Sorafenib Sandoz, Sorafenib Teva
  • Slovakia · Sorafenib, Sorafenib Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9a3e0928-2c63-4a74-8be5-6c61b3dd924a
GET /v1/drugs/9a3e0928-2c63-4a74-8be5-6c61b3dd924a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "200 mg",
  "packaging": "07613421047009 ¦ Rpz ¦ 137172\n112 tabl.",
  "substance": "Sorafenibi Tosilas 274 mg",
  "common_name": "Sorafenibum",
  "pl_product_id": "100421626",
  "pozwolenie_nr": "25994",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about gefitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.